4 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 4 of 4 clinical reviews.
A deep methodological analysis of the TRAVERSE Bone Fracture Substudy showing 43% increased fracture risk with testosterone in older hypogonadal men, examining randomization, blinding, endpoint adjudication, statistical frameworks, and what these design choices mean for clinical interpretation.
Deep-dive into the TRAVERSE bone fracture substudy's long-term follow-up findings, the 43% fracture increase signal with testosterone, durability of harm, and post-trial implications for TRT prescribing in older men.
Deep-dive into the TRAVERSE bone fracture substudy results showing a 43% increase in fractures with testosterone replacement therapy in older men, including effect sizes, confidence intervals, subgroup analyses, and time-course patterns.
Detailed breakdown of pre-specified and post-hoc subgroup analyses from the TRAVERSE Bone Fracture Substudy, examining which older hypogonadal men faced the greatest fracture risk increase with testosterone replacement therapy.